+55 31 99795-9214

International Holder and regulatory representation

Your product prepared for Brazil, the United States and Europe

CGA provides Holder and regulatory representation solutions for foreign companies entering Brazil and Brazilian companies seeking access to the United States and European Union. We support compliance with ANVISA, FDA and applicable CE marking requirements.

Market access

Regulatory representation in every direction

01

Brazil — ANVISA

For foreign companies entering Brazil

CGA can hold the ANVISA registration, supporting product regularization, importation and commercialization in Brazil.

  • ANVISA registration or notification holder
  • Local technical responsibility and representation
  • Documentation, labeling and post-market support
02

United States — FDA

For Brazilian companies entering the U.S. market

We support regulatory strategy and execution, including the applicable representation structure and FDA-related steps.

  • Classification and applicable regulatory pathway
  • Technical documentation preparation and review
  • Support for registrations, listings and submissions
03

European Union — CE Marking

For Brazilian companies entering Europe

We support CE marking readiness and the applicable regulatory representation structure in the European Union.

  • MDR or IVDR regulatory strategy
  • Technical documentation and conformity assessment
  • Support with representatives and Notified Bodies

Regulatory AI assistant

CGA Regulatory Assistant

Sourced technical guidance on ANVISA, GMP, ISO 13485, CE Marking, FDA and Brazilian Registration Holder services.

CGA Regulatory Assistant

Sourced technical guidance on ANVISA, GMP, ISO 13485, CE Marking, FDA and Brazilian Registration Holder services.

Hello! I am CGA Consulting's AI Assistant. I can clarify technical questions about standards, GMP and ANVISA registrations.

To personalize your service, this conversation is monitored by our technical team. By continuing, you agree to our Terms and Privacy Policy. Privacy

Why choose CGA

01

Integrated strategy

We assess the product, destination market and available documentation to define a consistent pathway.

02

International experience

We support ANVISA, FDA and CE marking projects while respecting each jurisdiction.

03

Regulatory continuity

We support changes, renewals, authority requests and post-market obligations.

04

Commercial security

A well-defined structure increases control over market entry and ongoing access.

How it works

From initial assessment to market maintenance

A structured regulatory journey tailored to your product and destination market.

  1. 01

    Regulatory assessment

    Analysis of product, intended use, classification, documentation and target markets.

  2. 02

    Strategy definition

    Definition of the applicable ANVISA, FDA or European Union pathway.

  3. 03

    Representation structure

    Definition and formalization of the appropriate Holder or regulatory representation model.

  4. 04

    Documentation and submission

    Preparation, review and adaptation of the required technical documentation.

  5. 05

    Access and maintenance

    Process follow-up and ongoing support for changes, renewals and post-market obligations.

Our clients

Which market do you want to enter?

Talk to CGA